<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-37R0CSWO</identifier><date>2013</date><creator>Boc, Marko</creator><creator>Boc, Nina</creator><creator>Mesti, Tanja</creator><creator>Reberšek, Martina</creator><relation>documents/doc/3/URN_NBN_SI_doc-37R0CSWO_001.pdf</relation><relation>documents/doc/3/URN_NBN_SI_doc-37R0CSWO_001.txt</relation><format format_type="volume">17</format><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 143-146, 157</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">1682299</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-37R0CSWO</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">maligni melanom</subject><subject language_type_id="slv">metastaze</subject><subject language_type_id="slv">tarčna zdravila</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">vemurafenib</subject><subject language_type_id="slv">zdravljenje</subject><title>klinični primer</title><title>Zdravljenje metastatskega malignega melanoma z vemurafenibom</title></Record>